Impact of China’s zero mark-up drug policy on drug cost of NCDs’ outpatients: an interrupted time series analysis

BACKGROUND: China proposed the Zero Markup Drug Policy (ZMDP), which popularized in tertiary hospitals across the country in 2017, to control drug expenditures’ rapid growth further and reduce the public’s medical burden. This study aims to evaluate the impact of ZMDP on the drug cost of chronic dis...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Health Serv Res
Hlavní autoři: Du, Jielin, Xie, Jiajia, Qian, Yan, Wu, Mingyue, Huang, Wenjing, Yin, Jin, Peng, Xin, Deng, Dan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8086109/
https://ncbi.nlm.nih.gov/pubmed/33926444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-021-06414-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky